Jefferies sees 2% downside potential for Zydus; puts ‘Hold’ rating with target price of Rs 630 Zydus Lifesciences holds a dominant position in the production of Asacol HD and is the leading player in the Mesalamine… 2 years ago
Zydus Lifesciences Q1 profit surges to Rs 1086.90 crore, revenue up 29.6% on US sales growth Zydus Lifesciences posted revenue from operations at Rs 5139.60 crore, up 29.6 per cent in comparison to Rs 3964.30 crore… 2 years ago
USFDA gives final nod to Zydus’ tablets for treatment of seizures Oxcarbazepine Tablets USP, 150 mg, 300 mg and 600 mg had annual sales of USD 105 mn in the United… 2 years ago
Zydus Lifesciences Q4 consolidated net profit dips 25.36 pc to Rs 296.6 cr Consolidated total revenue from operations stood at Rs 5,010.6 crore, as against Rs 3,805.6 crore in the corresponding period a… 3 years agoMay 18, 2023
Zydus Wellness Q4 net profit rise to Rs 145 crore The company had posted a consolidated net profit of Rs 133.3 crore in the year-ago period, Zydus Wellness said in… 3 years agoMay 17, 2023
USFDA tentatively approves Zydus’ tablets for seizures treatment According to data by IQVIA MAT in December 2022, Gabapentin Tablets had annual sales of USD 90 million in the… 3 years ago
Zydus Lifesciences gets exclusive marketing rights for OncoStem’s prognostic test for breast cancer Breast cancer is the leading cause of cancer in women in India and its risk increases with age. It is… 3 years ago
Zydus Lifesciences net profit plunge by 82.6% The company’s Research & Development (R&D) investments for the quarter stood at Rs 253 crore which is 6.1% of revenues. 3 years agoNovember 13, 2022
USFDA approves 2 generic drugs of Zydus Lifesciences According to the company, both drugs will be manufactured at the group’s formulation manufacturing facility in Ahmedabad SEZ. 3 years ago
Keki Mistry, Jaspal Bindra, other industry A-listers to share insights at the FE CFO Connect Conclave The FE CFO Connect Conclave 2022 is seeing some of the best minds from the Indian financial world and the… 3 years agoSeptember 18, 2022
Zydus Lifesciences Q1 consolidated net profit falls to Rs 518 crore However, excluding sales of COVID related products, the business grew 12 per cent year-on-year. 3 years agoAugust 10, 2022
Zydus gets USFDA nod for chemotherapy drug The approval granted by the US Food and Drug Administration (USFDA) is for Pemetrexed for injection, in strengths of 100… 4 years agoMay 26, 2022
Zydus Lifesciences gets USFDA nod for generic product The approval granted by the US Food and Drug Administration (USFDA) is for Cyanocobalamin injection in strengths of 1,000 mcg/ml,… 4 years agoApril 18, 2022
FE Pharma Summit to see industry titans swap ideas on steps to counter prickly challenges The two day FE Pharma Summit 2022 is also an attempt to leverage the ability of the Indian pharma stakeholders… 4 years agoMarch 23, 2022
Zydus Lifesciences gets USFDA nod to market generic version of colestipol hydrochloride tablets The approval by the US Food and Drug Administration is for colestipol hydrochloride of 1 mg strength, the company said… 4 years agoMarch 14, 2022
Zydus gets DCGI nod for drug to treat anaemia associated with chronic kidney disease The clinical development programme of Desidustat was one of the largest trials of its kind in India for Anemia in… 4 years agoMarch 7, 2022
Cadila Healthcare to be known as Zydus Lifesciences as part of new innovation centric corporate brand identity The company’s new brand identity brings together two hearts in purple and teal colours symbolising its commitment to science and… 4 years agoFebruary 25, 2022
